Treatment of new-onset type 1 diabetes with peptide DiaPep277 is safe and associated with preserved beta-cell function: extension of a randomized, double-blind, phase II trial (Q42504585)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment of new-onset type 1 diabetes with peptide DiaPep277 is safe and associated with preserved beta-cell function: extension of a randomized, double-blind, phase II trial |
scientific article |
Statements
1 reference
Treatment of new-onset type 1 diabetes with peptide DiaPep277 is safe and associated with preserved beta-cell function: extension of a randomized, double-blind, phase II trial (English)
1 reference
Raz I
1 reference
Avron A
1 reference
Tamir M
1 reference
Metzger M
1 reference
Symer L
1 reference
Eldor R
1 reference
Cohen IR
1 reference
Elias D
1 reference
1 reference
Identifiers
1 reference